IRIS
BELCARO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.241
EU - Europa 4.766
AS - Asia 2.965
SA - Sud America 82
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 14
AF - Africa 7
Totale 13.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.198
CN - Cina 1.029
SG - Singapore 1.005
UA - Ucraina 921
IE - Irlanda 900
TR - Turchia 643
IT - Italia 620
SE - Svezia 570
GB - Regno Unito 434
FR - Francia 365
DE - Germania 356
FI - Finlandia 190
RU - Federazione Russa 149
IN - India 139
PL - Polonia 76
BR - Brasile 65
BE - Belgio 35
ES - Italia 27
KR - Corea 27
CA - Canada 26
CZ - Repubblica Ceca 22
TH - Thailandia 22
AT - Austria 21
NL - Olanda 21
HK - Hong Kong 19
IR - Iran 18
AU - Australia 17
EU - Europa 13
JP - Giappone 13
VN - Vietnam 12
AR - Argentina 11
PT - Portogallo 11
TW - Taiwan 11
GR - Grecia 10
MX - Messico 10
CH - Svizzera 9
ID - Indonesia 8
NZ - Nuova Zelanda 7
RO - Romania 6
DK - Danimarca 5
HR - Croazia 4
IL - Israele 4
PH - Filippine 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
ZA - Sudafrica 3
EC - Ecuador 2
LT - Lituania 2
LU - Lussemburgo 2
MA - Marocco 2
MY - Malesia 2
NI - Nicaragua 2
SI - Slovenia 2
VE - Venezuela 2
AL - Albania 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GT - Guatemala 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
MC - Monaco 1
ME - Montenegro 1
PE - Perù 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.099
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.180
Chandler 906
Dublin 893
Singapore 779
Princeton 438
Izmir 362
Nanjing 349
Southend 346
Wilmington 189
Cambridge 188
Altamura 183
Santa Clara 155
Ashburn 136
Ann Arbor 129
Nanchang 120
Dearborn 110
Beijing 103
Boardman 71
Kraków 65
Shenyang 63
Hebei 56
Kunming 48
Tianjin 48
Woodbridge 44
Jiaxing 41
New York 32
Changsha 31
Norwalk 30
Brussels 29
Los Angeles 29
Munich 27
Washington 23
Chieti 22
Falls Church 21
Guangzhou 19
Hangzhou 19
Moscow 18
Brno 16
Grevenbroich 16
Lanzhou 16
Milan 16
Rome 16
Seattle 16
Houston 15
San Mateo 15
Helsinki 14
Jinan 14
Vienna 14
Foggia 13
Changchun 12
Ningbo 12
Shanghai 12
Hanover 11
London 11
Auburn Hills 10
Istanbul 10
Toronto 10
Augusta 9
Hong Kong 9
Bangkok 8
Collecorvino 8
Guardiagrele 8
Nuremberg 8
Orange 8
Amsterdam 7
Kuopio 7
Redwood City 7
Zhengzhou 7
Dong Ket 6
Frankfurt am Main 6
Hillsboro 6
Leawood 6
Madrid 6
Mcallen 6
Mountain View 6
Tehran 6
Warsaw 6
Atlanta 5
Chennai 5
Chiang Mai 5
Dallas 5
Garbagnate Milanese 5
Hanoi 5
Hefei 5
Seoul 5
Taipei 5
Telde 5
Tokyo 5
Yeongdeungpo-gu 5
Ada 4
Adelaide 4
Ankara 4
Athens 4
Auckland 4
Bari 4
Bengaluru 4
Bratislava 4
Chester 4
Cormeilles-en-Parisis 4
Halle 4
Totale 7.815
Salva come PNG Salva come JPEG
Nome #
Supplementary prevention and management of asthma with quercetin phytosome: a pilot registry 275
Beanblock® (standardized dry extract of Phaseolus vulgaris) in mildly overweight subjects: a pilot study. 127
Centella asiatica (Centellicum®) facilitates the regular healing of surgical scars in subjects at high risk of keloids. 125
Venoruton vs Daflon: evaluation of effects on qualità of life chronic venous insuffciency 124
Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). 123
The lung in systemic vasculitis: Radiological patterns and differential diagnosis 118
Robuvit® and endurance in triathlon: improvements in training performance, recovery and oxidative stress 114
Postoperative pulmonary infections: role of antibiotic treatment 112
A short-term vs a long-term infusion plan. A 20-week, European randomized trial. Analysis of efficacy and costs. 109
Aescin and microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 105
Pressure and microcirculatory effects of treatment with lercanidipine in hypertensive patients and in vascular patients with hypertension 102
Mononucleosis-related fatigue: supplementary management with Robuvit®. 101
TECA (Titrated Extract of Centella Asiatica): new microcirculatory, biomolecular, and vascular application in preventive and clinical medicine. A status paper. 100
Jet-lag: prevention with Pycnogenol. Preliminary report: evaluation in healthy individuals and in hypertensive patients 98
Incidence of perioperative stroke during peripheral revascularization or aortocoronary bypass in patients with carotid bruit and stenosis 96
Total triterpenic fraction of Centella asiatica in chronic venous insufficiency and in high-perfusion microangiopathy. 95
Robuvit® (Quercus robur extract) supplementation in subjects with chronic fatigue syndrome and increased oxidative stress. A pilot registry study 95
PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial 93
Prevention of edema and flight microangiopathy with Venoruton (HR), (0-[beta-hydroxyethyl]-rutosides) in patients with varicose veins 92
Topical heparin: New observations 92
The value of segmental pressure measurement in the assessment of peripheral vascular disease. 91
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings 91
Evaluation of treatment of diabetic microangiopathy with total triterpenic fraction of Centella Asiatica: a clinical prospective randomized trial with a microcirculatory model. 90
Temporary kidney dysfunction: Robuvit® supplementation in initial, transient kidney insufficiency and micro-macro albuminuria 90
Treatment of ankle sprain in patients with vascular diseases of the lower limbs 89
Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study 89
Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. 88
Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome 88
Circulating endothelail cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with venoruton 87
Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. 87
Total triterpenic fraction of Centella asiatica in the treatment of venous hypertension: a clinical, prospective, randomized trial using a combined microcirculatory model. 85
Treatment of Osteoarthritis with Pycnogenol®. The SVOS (San Valentino Osteo-arthrosis Study). Evaluation of Signs, Symptoms,Physical Performance and Vascular Aspects 85
Improvement in mood, oxidative stress, fatigue, and insomnia following supplementary management with Robuvit® 84
Robuvit®: improvement of fatigue in medical convalescence. 83
Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study 82
Nomograms used to define the short-term treatment with PGE(1) in patients with intermittent claudication and critical ischemia. The ORACL.E (Occlusion Revascularization in the Atherosclerotic Critical Limb) Study Group. The European Study. 80
Management of functional, hepatic damage after chemotherapy with Liverubin (pharma-standard silymarin). 80
[European trial of PGE1 alpha cyclodextrin. Short-term vs. long-term therapy in intermittent claudication] 79
Thyroid cysts treatment with the sclerosing agent Atossiclerol. Long-term (5 to 15 years) follow-up. 79
Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment. 79
Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. 77
Cramps and Muscular Pain: Prevention with Pycnogenol((R)) in Normal Subjects, Venous Patients, Athletes, Claudicants and in Diabetic Microangiopathy 77
Venous ulcers: microcirculatory improvement and faster healing with local use of Pycnogenol 77
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. 77
Prevention of recurrent venous thrombosis and post-thrombotic syndrome. 77
Aescin: microcirculatory activity. Effects of accessory components on clinical and microcirculatory efficacy. 76
Effects of pycnogenol on endothelial dysfunction in borderline hypertensive, hyperlipidemic, and hyperglycemic individuals: the borderline study. 76
Mirtogenol® supplementation in association with dorzolamide-timolol or latanoprost improves the retinal microcirculation in asymptomatic patients with increased ocular pressure 76
O-(beta-hydroxyethyl)-rutosides systemic and local treatment in chronic venous disease and microangiopathy: an independent prospective comparative study 74
Superficial vein thrombosis (SVT), diffusion of thrombotic diseases, and increased global thrombogenicity: SVT as an important spy disease indicating environmental contamination by estrogens - Introduction 74
Behçet syndrome: effects of Pycnogenol® supplementation during regression phases. 74
Treatment of Diabetic Microangiopathy and Edema with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled Randomized Study. 73
5-Year Control and Treatment of Edema and Increased Capillary Filtration in Venous Hypertension and Diabetic Microangiopathy Using O-(β-Hydroxyethyl)-Rutosides: A Prospective Comparative Clinical Registry 73
[Comparison of netilmicin with other aminoglycosides in severe surgical infections]. 73
Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®). 73
Interaction study between antiplatelet agents, anticoagulants, diabetic therapy and a novel delivery form of quercetin. 73
Microcirculatory Effects of Total Triterpenic Fraction of Cenetlla asiatica in Chronic Venous Hypertension: Measurement by Laser Doppler, TcPo2-CO2, and Leg Volumetry 72
Treatment of edema and increased capillary filtration in venous hypertension with total triterpenic fraction of Centella asiatica: a clinical, prospective, placebo-controlled, randomized, dose-ranging trial. 72
Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy) 72
Clinical evaluation of defibrotide in the treatment of arterial and venous vascular disease. A preliminary report. 72
[Breast cancer. Epidemiology and other factors related to incidence in various populations]. 72
Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study 72
Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study 72
Managing ulcerative colitis in remission phase: usefulness of Casperome®, an innovative lecithin-based delivery system of Boswellia serrata extract 72
Supplementary management of functional, hepatic damage with Liverubin (pharma-standard Silymarin). A 3-month registry. 72
Artificial Saliva in Diabetic Xerostomia (ASDIX): Double Blind Trial of Aldiamed® Versus Placebo 72
Oxygen-free radical decrease in hypertensive patients treated with lercanidipine 70
THE VENOUS CLINIC 70
Local heparin, superficial vein thrombosis 70
Microcirculatory effects of Viatromb® spray gel heparin in chronic venous insufficiency: Evaluation of TcPO2 and PCO2 - A product evaluation study 70
Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10 year follow-up study (the CAFES-CAVE Study). 69
Treatment of long-distance intermittent claudication with pentoxifylline: a 12-month, randomized trial. 69
Increase in Echogenicity of Echolucent Carotid Plaques After Treatment with Total Triterpenic Fraction of Centella Asiatica: A Prospective, Placebo-Controlled, Randomized Trial. 69
Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. 69
Capillary filtration in venous hypertension: evaluation with the vacuum suction chamber device and strain-gauge plethysmography. 69
HR (Paroven, Venoruton; 0-(beta-hydroxyethyl)-rutosides) in venous hypertensive microangiopathy: a prospective, placebo-controlled, randomized trial. 68
Improvement in cochlear flow in patients with tinnitus with the complex supplement Acustop: a product evaluation 68
Trombosi venose ed embolie 68
The COFU3 Study. Improvement in cognitive function, attention, mental performance with Pycnogenol® in healthy subjects (55-70) with high oxidative stress 68
Bilberry extracts are not created equal: the role of non anthocyanin fraction. Discovering the "dark side of the force" in a preliminary study 68
Supplementation with Robuvit® in post-mastectomy post-radiation arm lymphedema. 68
An open, supplement, registry study Arborvitae (R) for prevention of arthrosis-related pain during exercise 68
Pycnogenolà supplementation improves health risk factors in subjects with metabolic syndrome 68
Laser doppler flux in the venous wall 67
Effects of shock waves on microcirculation, perfusion, and pain management in critical limb ischemia. 67
Pycnogenol may alleviate adverse effects in oncologic treatment 67
Activity of some physiological modulators in reducing the side effects of levothyroxine in patients suffering from primary hypothyroidism. 67
null 67
Assessment of the activity of an oral contraceptive on the levels of oxidative stress and changes in oxidative stress after co-treatment with two different types of physiological modulators with antioxidant action. 66
Supplementation with high titer cranberry extract (Anthocran®) for the prevention of recurrent urinary tract infections in elderly men suffering from moderate prostatic hyperplasia: a pilot study 66
Pycnogenol®+Centellicum®, post-stent evaluation: prevention of neointima and plaque re-growth 66
Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment. 66
PycnoRacer®, a fitness drink including Pycnogenol®, improves recovery and training in the Cooper test 66
Prevention of diffuse, minimal lymphatic "retention" with Robuvit®: a concept, supplement registry study 66
A controlled study shows daily intake of 50 mg of French Pine Bark Extract (Pycnogenol®) lowers plasma reactive oxygen metabolites in healthy smokers. 66
[Reduction of cardiovascular morbidity/mortality in arteriopathies treated ith PGE1 alpha-cyclodextrin] 65
LINFAVENIX: improvement of signs and symptoms of chronic venous insufficiency and microangiopathy 65
Effects of a curcumin-based supplementation in asymptomatic subjects with low bone density: a preliminary 24-week supplement study 65
Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study 64
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. 64
Totale 8.211
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020518 0 0 0 0 0 0 0 0 65 144 273 36
2020/20211.109 217 21 233 30 87 262 20 9 84 92 19 35
2021/2022870 16 18 15 166 77 25 19 65 68 17 101 283
2022/20232.726 272 407 157 284 234 572 181 177 276 26 88 52
2023/20241.149 88 50 65 26 49 288 335 38 24 50 33 103
2024/20252.000 266 689 531 55 78 94 64 149 74 0 0 0
Totale 13.579